CITIGROUP INC - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 75 filers reported holding DESIGN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,826
-97.3%
774
-92.8%
0.00%
Q2 2023$67,511
+243.4%
10,716
+214.5%
0.00%
Q1 2023$19,658
-98.3%
3,407
-96.9%
0.00%
-100.0%
Q4 2022$1,125,112
+96.4%
109,660
+220.0%
0.00%
Q3 2022$573,000
+381.5%
34,267
+302.5%
0.00%
Q2 2022$119,000
-60.6%
8,514
-54.5%
0.00%
Q1 2022$302,000
-50.0%
18,722
-33.6%
0.00%
Q4 2021$604,000
+65.9%
28,199
+13.7%
0.00%
Q3 2021$364,000
-22.7%
24,808
+4.7%
0.00%
Q2 2021$471,00023,6900.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders